Aceclofenac
Sponsors
Cannaxan GmbH, Apurano Pharmaceuticals GmbH, Janssen Korea, Ltd., Korea, Dong Wha Pharmaceutical Co. Ltd., Cairo University, Chung Shan Medical University
Conditions
Chronic back painDrug Interaction PotentiationHealthyIrreversible PulpitisOsteoarthritisRheumatoid ArthritisSymptomatic Irreversible Pulpitis
Phase 1
Drug-drug Interaction Between Aceclofenac 200 mg and Esomeprazole 20 mg in Healthy Male Volunteers
NCT03127046
Start: 2017-03-31End: 2017-04-23Updated: 2017-04-25
Pharmacokinetic Interaction Between Tegoprazan and NSAIDs After Multiple Oral Dosing in Healthy Male Volunteers
CompletedNCT04639804
Start: 2020-06-06End: 2020-07-29Updated: 2020-11-23
Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Naproxen, Aceclofenac, Celecoxib and Ilaprazole
CompletedNCT05237297
Start: 2022-02-17End: 2022-07-27Updated: 2023-06-28
Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Ilaprazole and Aceclofenac
CompletedNCT05558150
Start: 2022-11-10End: 2022-12-22Updated: 2023-06-28
Phase 2
Pre-operative Aceclofenac on the Anesthetic Efficacy of IANB in Symptomatic Irreversible Pulpitis
CompletedNCT03146481
Start: 2016-07-31End: 2017-07-31Updated: 2017-11-07
Pretreatment Aceclofenac Effect on Pain and Analgesic Intake After Endodontic Treatment
CompletedNCT03335007
Start: 2015-05-31End: 2017-07-31Updated: 2017-11-07
Phase 3
Phase 4
A Comparative Study of Tramadol Hydrochloride Plus Acetaminophen Tablets Maintenance Versus Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Maintenance in Participants With Knee Osteoarthritis
CompletedNCT00635349
Start: 2007-05-31End: 2009-04-30Updated: 2013-07-22
Etoricoxib vs Aceclofenac in the Treatment of Patients With Rheumatoid Arthritis
CompletedNCT04144101
Start: 2007-03-01End: 2007-07-31Updated: 2019-10-30